COVID-19 Pandemic Tied to Increase in Overdose Deaths
There was an increase in drug overdose deaths in San Francisco during the COVID-19 pandemic.
Pain
Patients With Opioid Dependence Prefer Depot vs Sublingual Buprenorphine
The researchers’ objective was to compare the patient satisfaction of adult outpatients with opioid dependence who were administered buprenorphine subcutaneously by depot vs those given the drug sublingually.
Factors Identified Putting Youth on High-Risk Trajectory After First Opioid Prescription
High- and low-risk trajectories are identifiable for youth following their first opioid prescription.
Pregabalin Superior to Placebo for SCI-Related Chronic Pain, But No Significant Effect With Cannabinoids
The researchers aimed to determine the efficacy and withdrawal rates of therapies used to manage the chronic pain of spinal cord injury as well as the incidence of adverse events.
Stigma Associated With Poorly Understood Chronic Pain Detrimental to Overall Well-Being
The researchers compared well-being and feelings of stigmatization in people with well understood conditions and in those with less understood condition, fibromyalgia, using daily diaries.
Active Interventions Needed to Ensure Patients Properly Dispose of Excess Opioid Medications
In a 1:1:1 ratio, patients were randomly assigned to receive a drug disposal kit and fact sheet, fact sheet alone, or no additional items when filling their opioid prescription.
Zynrelef Approved to Treat Postoperative Pain for Up to 72 Hours
The needle-free product is intended for single-dose administration only.
Depot Buprenorphine Improves Outcomes in Opioid Dependence
Participants with opioid dependence receiving subcutaneously administered depot buprenorphine have improved treatment satisfaction compared with those receiving sublingual buprenorphine.
Cannabis Use Disorder in Pregnancy Tied to Worse Infant Outcomes
Prenatal cannabis use disorder (CUD) is associated with higher odds of major adverse neonatal outcomes.
Supply Steady for Existing Patients Receiving Opioids During COVID-19
Existing patients receiving opioid analgesics and buprenorphine for opioid use disorder have continued to receive medications during the COVID-19 pandemic.
- Loading...
Loading...
Next post in Practice Management
Loading... 
Loading...